ImmuCell Corporation
ICCC
$5.07
-$0.0662-1.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.16M | -3.81M | -4.05M | -3.90M | -5.77M |
| Total Depreciation and Amortization | 2.69M | 2.69M | 2.71M | 2.73M | 2.72M |
| Total Amortization of Deferred Charges | 42.60K | 41.90K | 39.80K | 30.90K | 22.60K |
| Total Other Non-Cash Items | 191.20K | 259.40K | 382.60K | 403.40K | 472.70K |
| Change in Net Operating Assets | -406.50K | 459.30K | 682.80K | -758.00K | -2.11M |
| Cash from Operations | 357.90K | -362.10K | -230.60K | -1.49M | -4.67M |
| Capital Expenditure | -465.70K | -350.80K | -682.90K | -1.28M | -1.89M |
| Sale of Property, Plant, and Equipment | 4.50K | 4.50K | 6.90K | 2.50K | 2.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 115.10K | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -461.20K | -231.20K | -676.10K | -1.28M | -1.89M |
| Total Debt Issued | -- | 0.00 | 4.00M | 4.00M | 5.00M |
| Total Debt Repaid | -1.47M | -1.45M | -3.41M | -3.30M | -3.19M |
| Issuance of Common Stock | 4.65M | 3.85M | 271.50K | 18.80K | 18.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -296.80K | 11.60K | -86.50K | -86.50K | -81.50K |
| Cash from Financing | 2.88M | 2.41M | 776.70K | 636.40K | 1.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.78M | 1.82M | -130.00K | -2.14M | -4.81M |